Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
27.9M
-
Number of holders
-
193
-
Total 13F shares, excl. options
-
17.8M
-
Shares change
-
+935K
-
Total reported value, excl. options
-
$1.7B
-
Value change
-
+$94.8M
-
Put/Call ratio
-
1.51
-
Number of buys
-
96
-
Number of sells
-
-73
-
Price
-
$95.52
Significant Holders of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) as of Q1 2019
219 filings reported holding ENTA - ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share as of Q1 2019.
ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) has 193 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.8M shares
of 27.9M outstanding shares and own 63.89% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.55M shares), VANGUARD GROUP INC (1.62M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.37M shares), FARALLON CAPITAL MANAGEMENT LLC (940K shares), STATE STREET CORP (920K shares), JANUS HENDERSON GROUP PLC (874K shares), FIRST MANHATTAN CO (665K shares), RENAISSANCE TECHNOLOGIES LLC (646K shares), DIMENSIONAL FUND ADVISORS LP (629K shares), and AMERIPRISE FINANCIAL INC (510K shares).
This table shows the top 193 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.